文献.pdf就快要消失啦!Elsevier已经退出了全新的文献阅读试用装,名为Article of the Future,以后网上查阅文献不再是固定的introduction--materialmethod--results...格式,整个页面分为左中右三块,左边是是文章目录,方便随时跳转到感兴趣的section,右边是引文链接,随时可以查看引文,中间则在abstract前有个highlight,把本文最重要的发现、论点总结出来,然后是abstract--introduction--materialmethod--results...但是图片什么的可以放大缩小,可以调整阅览模式,云云。 好激动啊,这么好的阅读模式!但愿我的文章能发表者在改版后的Elsevier上!咔咔! 参见: http://www.articleofthefuture.com/about
在此“徐如人院士执教六十年暨八十华诞”之际, 衷心祝贺徐如人院士等编著的Elsevier英文版“Modern Inorganic Synthetic Chemistry(现代无机合成化学)”一书问世! 这是徐如人老师和吉林大学化学学院他的同事们几十年的工作辛勤积累成果!此书的印刷精美,所附的彩色原图都用彩色印制,非常漂亮! 我有幸参加了其中第7章“CVD and its Related Theories in Inorganic Synthesis and Materials Preparations (化学气相淀积及其相关理论在无机合成及材料制备中的应用)”一章的写作。 我深信国人学者在国际上出版的英文著作会越来越多!
实例一: The proof has been checked carefully and no further changes to it.Thanks for your great help and now we send back the proof to you. 实例二(更具体): proof的修改问题(ZHUAN) 当通讯作者收到文章的proof(校样)后,可以修改作者信息、联系方式、增添作者、调换作者顺序、添加基金等,如果删除作者、调换作者,尤其是第一作者和通讯作者时,大多期刊编辑会要求提供变更说明并签字的证明。这里不详述了。随proof附件的,大多期刊还有query和annotate文件(有的期刊没有annotate文件) Proof还有内容的修改,包括期刊编辑校对时给你的pdf标注,有的期刊没有pdf标注,直接将排版好的proof发给你校对。不管怎样,作者可以在编辑发给你的proof中直接进行修改错误的内容,一定要注意按照proof修改的要求进行删除、增添、批注等操作。没有annotate文件的,就按照pdf工具栏里的各个图标所表示的意思或功能进行操作,在proof中,为了区别排版编辑对你稿件的修改,作者修改proof时除了删除、增添、批注等操作外,还可以对这些删除、增添、批注等进行黄色加亮显示。修改好后,在文档文件名后加上_corrected字样,然后将附件回复到编辑邮箱,记得要提醒编辑收到后给你回信。 Query文档里,response的内容可以在下方填上(针对query,一条条列出修改页数和行数、修改内容和备注说明);如果已经在proof中修改了(修改信息对Query进行了回答),可以在response里指出修改页和行数、备注说明。Query文档写好后打印传真给指定的传真号。同样,记得提醒编辑给你回信。 本帖附件1:INSTRUCTIONS ON THE ANNOTATION OF PDF FILES (如何对pdf文档进行批注、修改等说明) 本帖附件2:AUTHOR QUERY FORM 本帖附件3:MAMT_1528_corrected (黄色加亮部分是作者的修改,其它地方是排版编辑的修改。)本文已经正式出版。 方东明 北京大学微电子学研究院 附上proof时的往返email信件 Dear Sir/Madam, The attached document is the corrected proof. All corrections are highlighted in yellow. Please give me a reply when you receive the attachment. Thank you very much. Best Regards, Dongming Fang 2009-01-12
Elsevier Joins CrossRef Cited-by Linking 16 November, London, UK-Elsevier now participates in CrossRef's Cited-by Linking Service . The service allows CrossRef member publishers to display links on an article page to other articles that cite that particular document. Elsevier joins over 200 publishers that deposit references from their scholarly content and display citing links from CrossRef publishers back to that content. Since August, CrossRef DOI-based cited-by links have been added to over 10 million Elsevier articles on SciVerse ScienceDirect. The next step in Elsevier's implementation will be to submit approximately 200 million references to CrossRef from its large library of scholarly publications. Depositing these references will allow other CrossRef members to display links to Elsevier articles that cite their content. Having Elsevier join Cited-by Linking is great news for researchers, commented Ed Pentz, CrossRef's Executive Director. As with all CrossRef services, the more publishers who participate, the greater the benefit to those in the scholarly communications system. Adding the huge number of Elsevier articles and references to the system will greatly improve individual researchers' ability to evaluate the importance of the literature they look at and to navigate to related research. Elsevier has added CrossRef Cited-by Linking to our existing navigation features on SciVerse ScienceDirect because we believe it will further improve researchers' ability to search and discover scholarly content that is relevant to their work, notes Chris Shillum, Vice President for Product Management, Platform and Content at Elsevier. We remain strongly committed to providing researchers access to trusted information tailored to their research needs, and this enhancement reflects that commitment. CrossRef Cited-by Linking (previously known as Forward Linking) has grown steadily since its inception in 2006. Currently, almost 20% of the 44 million CrossRef DOIs deposited also have their references available to create Cited-by Links. A total of more than 125 million Cited-by Links exist among participating publishers. Nearly 17 million CrossRef DOIs have at least one Cited-by Link referencing them. Cited-by Linking is an optional service for CrossRef members and is available at no additional cost. More information is available at the CrossRef web site: http://www.crossref.org/citedby.html About CrossRef CrossRef ( http://www.crossref.org ) is a not-for-profit membership association of publishers. Since its founding in 1999, CrossRef has provided reference linking services for 44 million content items, i ncluding journal articles, conference proceedings, books, book chapters, reference entries, technical reports, standards, and data sets. CrossRef currently has 980 voting members, representing 3237 publishers. Almost 60% of CrossRef publishers are not-for-profit organizations. CrossRef also serves more than 1600 libraries and provides citation look-up services to a number of affiliated organizations.
2007 年创刊的《临床血脂学杂志》(Journal of Clinical Lipidology),ISSN: 1933-2874 ,双月刊,Elsevier出版集团(ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710)出版,2007年入选 Web of Science的Science Citation Index Expanded,目前在SCI数据库可以检索到该期刊2007年的第1卷第1期到2010年第4卷第3期共220篇论文。 2009 年 JCR 首次公布该刊的影响因子为 1.462 。 220 篇文章包括学术论文117篇、社论55篇、评论31篇、通讯8篇、更正4篇、传记3篇、会议论文2篇。 220 篇文章的主要国家分布:美国163篇,加拿大11篇,英国7篇,意大利4篇,埃及、德国各3篇,澳大利亚、巴西、希腊、伊朗、以色列、尼日利亚、挪威、南非各2篇等。 中国学者以合作者(非通讯作者单位)在该刊上发表论文1篇。 220篇文章共被引用231次(其中2007年被引用4次、2008年被引用29次、2009年被引用109次、2010年被引用89次),平均引用1.05次, H指数为7(有7篇文章每篇最少被引用7次)。 《临床血脂学杂志》(Journal of Clinical Lipidology )投稿指南: 《临床血脂学杂志》是美国国家脂质协会(National Lipid Association)的官方刊物,该刊支持多种多样的医疗专业人士的工作,以减轻减肥和油脂代谢紊乱的发病率和死亡率。该杂志的读者群涵盖广泛的医学团体,包括心脏专家、内分泌科专家、初级保健医生以及那些参与治疗这类疾病的人,如糖尿病、高血压和肥胖症。该杂志还针对以上各类疾病的健康专职者、药剂师、护士和营养学家。 网址: http://www.sciencedirect.com/science/journal/19332874 编委会: http://www.elsevier.com/wps/find/journaleditorialboard.cws_home/710566/editorialboard 作者指南: http://www.elsevier.com/wps/find/journaldescription.cws_home/710566/authorinstructions 在线投稿: http://ees.elsevier.com/jclinlipid/ 《临床血脂学杂志》(Journal of Clinical Lipidology )热点论文: 1.标题: LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study-Implications for LDL management 作者: Cromwell WC, Otvos JD, Keyes MJ, et al. 来源出版物: JOURNAL OF CLINICAL LIPIDOLOGY 卷: 1 期: 6 页: 583-592 出版年: DEC 2007 被引频次: 26 2.标题: Niacin plus simvastatin reduces coronary stenosis progression among patients with metabolic syndrome despite a modest increase in insulin resistance: A subgroup analysis of the HDL-Atherosclerosis treatment study 作者: Vittone F, Chait A, Morse JS, et al. 来源出版物: JOURNAL OF CLINICAL LIPIDOLOGY 卷: 1 期: 3 页: 203-210 出版年: JUL 2007 被引频次: 16 3.标题: Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice 作者: Sniderman AD 来源出版物: JOURNAL OF CLINICAL LIPIDOLOGY 卷: 2 期: 1 页: 36-42 出版年: FEB 2008 被引频次: 12 4.标题: Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOAST II (high-dose) study 作者: Ballantyne CM, Davidson MH, McKenney JM, et al. 来源出版物: JOURNAL OF CLINICAL LIPIDOLOGY 卷: 2 期: 2 页: 79-90 出版年: APR 2008 被引频次: 9 5.标题: Peptide mimetics of apolipoproteins improve HDL function 作者: Navab M, Anantharamaiah GM, Reddy ST, et al. 来源出版物: JOURNAL OF CLINICAL LIPIDOLOGY 卷: 1 期: 2 页: 142-147 出版年: MAY 2007 被引频次: 9 6.标题: Long-term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia 作者: Bays HE, Jones PH, Mohiuddin SM, et al. 来源出版物: JOURNAL OF CLINICAL LIPIDOLOGY 卷: 2 期: 6 页: 426-435 出版年: DEC 2008 被引频次: 8 7.标题: Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B 作者: Sniderman A, Tremblay A, Bergeron J, et al. 来源出版物: JOURNAL OF CLINICAL LIPIDOLOGY 卷: 1 期: 4 页: 256-263 出版年: AUG 2007 被引频次: 8 8.标题: The importance of non-HDL cholesterol reporting in lipid management 作者: Blaha MJ, Blumenthal RS, Brinton EA, et al. 来源出版物: JOURNAL OF CLINICAL LIPIDOLOGY 卷: 2 期: 4 页: 267-273 出版年: AUG 2008 被引频次: 7 9.标题: Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses 作者: Abate N, Catapano AL, Ballantyne CM, et al. 来源出版物: JOURNAL OF CLINICAL LIPIDOLOGY 卷: 2 期: 2 页: 91-105 出版年: APR 2008 被引频次: 5 10.标题: Plant sterols and stanols: Their role in health and disease 作者: Patel SB 来源出版物: JOURNAL OF CLINICAL LIPIDOLOGY 卷: 2 期: 2 页: S11-S19 出版年: APR 2008 被引频次: 5
Please open the online version of this message if the HTML is not correctly displayed. Share this with colleagues on your social network To unsubscribe, please click Unsubscribe Visit the Elsevier Booth at... ACS Spring National Meeting 2010 Booth #1117 March 21-25, 2010 San Francisco, USA If you are attending this American Chemical Society National Meeting Exposition, make sure you do not miss... Free Reaxys Workshops Teaching Students to Use Reaxys Water Sustainability Symposium Tuesday, March 23 Sponsored by Elsevier Or stop by our booth to: Enjoy the Chocolate Fountain Meet and Greet Event on Monday, March 22, 3:30-5pm Learn about Hazmat Navigator, our new online chemical safety tool Enter our Daily Raffle (prizes include an Amazon Kindle) Learn about our high and increasing Impact Factor Journals Take advantage of the Special Discounts on Our New and Bestselling Titles Top Free Reaxys workshops - an Introduction to Reaxys Free Reaxys workshops Free workshop: getting to know Reaxys - how to enhance your chemistry research Learn how Reaxys can reduce the time you currently spend locating chemical reactions and substance data. Reaxys integrates reaction and substance data searching with synthesis planning and gives immediate access to relevant results. Discover how to easily locate the correct information via the appealing interface, prepare reports, export molecules, reactions and associated data and prepare your synthesis without wasting time reviewing unnecessary articles. Learn how to make the most of the smart tools and convenient results visualization which will enable you to access the relevant information quickly and easily. Lunch is provided and we look forward to seeing you there. Location: Moscone Center When: Monday March 22, 12-2.30pm, Room 110 Register here Tuesday March 23, 12-2.30pm, Room 111 Register here And if you can't make either session please stop by booth #1117 for a Reaxys demo. Teaching students to use Reaxys Sue Cardinal, Chemistry Librarian at Rochester University is giving a short session on ' Teaching students to use Reaxys in order to find synthetic methods for making benzylic acid from benzaldehyde '. All ACS delegates can attend this informative session which also deals with the larger theme of sustainable education and partnership between faculty and librarians - more details about the symposium can be found on the CINF website . Top Elsevier Co-Sponsors Water Quality Symposium Participate in the Sustainability of Water Quality Symposium In partnership with the Analytical Division of ACS, Elsevier Chemistry Books will sponsor an all-day symposium on water quality and sustainability. Details: Tuesday, March 23, 2010 The Moscone Center, Room 3012 West Bldg. AM session: 8:30 am - 12:25 pm PM session: 1:30 - 5:25 pm This multidisciplinary session brings together researchers and professionals from around the world. Topics include bacteria, pharmaceuticals, and heavy metals removal; marine debris and plastic decomposition; and new EPA methods. Get details at the Analytical Division website. Learn more about our titles in this research area, including Handbook of Water Purity and Quality. Top Chocolate Fountain Meet and Greet Event at the Booth Join Us Monday, March 22, at 3:30pm for a Meet and Greet around our Chocolate Fountain Don't miss this opportunity to preview our new products, meet our authors and editors to discuss careers in chemistry, and talk with your colleagues-all while dipping your favorite treat (strawberries, macaroons) in our chocolate fountain... Preview an advance copy of our new reference work, Comprehensive Natural Products II: Chemistry and Biology , edited by Lew Mander and Hung-Wen (Ben) Liu. Test-drive our new tool for chemical safety information, Hazmat Navigator - and meet members of the editorial board. Receive a special gift in celebration of these exciting new products! Can't attend the meeting? Check out the links above to find out how these products can enhance your research productivity and provide insight into the helpful and harmful effects of chemical compounds. While you're at the booth, be sure to browse our books, eBooks, and other products on display, and save 20% on your purchase. Don't forget to enter our daily raffle-we're giving away books, articles, an Amazon Kindle, and more! Top High and Increasing Impact Factor Journals Elsevier: publishing the most cited and highest Impact Factor Journals in their fields 1st Impact Factor Title in Inorganic Nuclear Chemistry 2nd and 4th Most Cited Titles in Organic Chemistry 2 out of the top 3 Impact Factor Titles in Analytical Chemistry 7 out of the top 8 Impact Factor Titles in Electrochemistry 7 out of the top 15 Impact Factor Titles in Physical Chemistry 11 out of the top 20 Impact Factor Titles in Spectroscopy 15 out of the top 16 Impact Factor Titles in Chemical Engineering More information on our high and increasing Impact Factor titles * Thomson Reuters Journal Citation Reports 2009 Top New and Bestselling Titles on Display Browse our books and eBooks-and save! Save 20% on these new print and online reference works*, as well as other new/bestselling titles available on the stand: Comprehensive Natural Products II: Chemistry and Biology Ten-Volume Set Editors-in-Chief: Lew Mander and Hung-Wen (Ben) Liu Features 100% new content and a biological focus-preview an advanced copy of the set at ACS! Encyclopedia of Spectroscopy and Spectrometry, Second Edition Three-Volume Set Editors-in-Chief: John C. Lindon, George E. Tranter, and David Koppenaal Now available, with cutting-edge content and a new co-author-see the set at ACS! Comprehensive Membrane Science and Engineering Four-Volume Set Editors-in-Chief: Enrico Drioli and Lidietta Giorno The definitive new work for researchers and industry professionals, available July 2010. Reserve your copy and save! *20% introductory pricing on reference works expires end of third month after publication. Browse all titles on display at the ACS Spring 2010 Meeting. Join the Elsevier Chemistry Community on Facebook .
Elsevier Cordially Invites You to an Exclusive Webcast: Coaching Early Career Researchers It is recognized internationally that coaching researchers who are early in their career is a top priority, but far too often it seems to slip through the cracks; not because it is so hard to do, but because it often requires individual attention and is therefore a time and resource consuming process. In this webcast Emeritus Professor Alan Johnson presents unique insights into how you can help your early career researchers advance their career with a few efficient, effective, and well planned steps. We would like to invite you to take this opportunity to ask Professor Alan Johnson in person for advice on guiding your early career researchers. Who should attend this webcast? Anyone who is interested in helping their researchers advance their careers, such as: Faculty Research Coordinators, Directors of Research, Deans of Graduate School, Senior Graduate School Staff, University Administrators. In addition Deputy Vice Chancellors may want to forward this invitation to appropriate staff members. Emeritus Professor Alan Johnson AM, M.A. (Hons), M.Ed.Mgmt., B.App.Sc, Ph.D., D.Sc. Emeritus Professor Alan Johnson AM has 30 years of experience in research, research management, and research training in a range of organizations including universities, Australian Government agencies, and international research organizations. During his research career, he published over 100 internationally refereed journal articles and received over $3.5 million in competitive grant funding. Professor Johnson was a member of several international commissions and councils and has been decorated with a number of awards. His most recently held academic position was as Deputy Vice Chancellor of Research at the University of Adelaide Australia. Over the course of his career Professor Johnson has engaged in the mentorship of numerous researchers, which has given him great satisfaction. With this webcast he would like to encourage senior university staff to coach their early career researchers to enable many more researchers to be able to pursue their career through the challenges of academia. In 2007, Professor Johnson established an international consultancy business, Research Management Services International Pty. Ltd. Date: January 14, 2010 Time: 19:00 GMT, 14:00 EST Local Times, 14 January: Los Angeles - 11:00 Denver - 12:00 Chicago - 13:00 New York - 14:00 Buenos Aires - 16:00 London - 19:00 Amsterdam Berlin, Paris - 20:00 Cairo, Johannesburg - 21:00 Dubai - 23:00 Local Times, 15 January : Calcutta - 00:30 Bangkok - 02:00 Sydney - 06:00 Auckland - 08:00
1. Submitted to Journal当上传结束后,显示的状态是Submitted to Journal,这个状态是自然形成的无需处理。 2. With editor如果在投稿的时候没有要求选择编辑,就先到主编那,主编会分派给别的编辑。这当中就会有另两个状态: 3. Editor assigned 4. Editor Declined Invitation 如果编辑接手处理了就会邀请审稿人了。 5. Reviewer invited 如果审稿人接受那就会是以下状态: 6. Under review 这应该是一个漫长的等待。当然前面各步骤也可能很慢的,要看编辑的处理情况。 如果被邀请审稿人不想审,就会decline,编辑会重新邀请别的审稿人。 7. required review completed 审稿结束,等编辑处理。 8. Decision in Process到了这一步就快要有结果了,编辑开始考虑是给修改还是直接拒,当然也有可能直接接受的,但可能性很小,呵呵。 9. Minor revision/Major revision这个时候可以稍微庆祝一下了,问题不大了,因为有修改就有可能。具体怎么改就不多说了,谦虚谨慎是不可少的。 10. Revision Submitted to Journal 又开始了一个循环。 11. Accepted如果不要再审,只是小修改,编辑看后会马上显示这个状态,但如果要再审也会有上面的部分状态。一步会比较快,但也有慢的。看杂志的。 还有个状态是Rejected。希望不要出现。 其他库的状态,基本是大同小异,供参考: In the Rapid Review system, your manuscript has a different status assigned to it at various stages in the process. Below is a list of the status descriptions used with brief explanations. Incomplete Submission... you have begun the submission process. The submission has been assigned a temporary (TMP) manuscript number. You must complete the submission process. Finish My Submission... by viewing and approving the MS PDF. Once this is done, the submission will be assigned a permanent manuscript number. MS at Check-In... the manuscript is pending a quality check by the staff or editor. This involves verifying that the MS PDF contains a complete manuscript (text, tables, figures, etc.) and is suitable for review purposes. Conversion to PDF in Process... If the manuscript was submitted digitally, the MS PDF did not pass the QC process and is not suitable for review purposes. The staff may be in the process of converting the digital files to a new MS PDF or staff may have requested that the author send new file. The Journal Office is waiting for the fileto upload for conversion purposes. MS Being Pre-screened... if you submitted a manuscript to a journal whose review process includes pre-screening, this status indicates that the manuscript (or the abstract) is currently being pre-screened to determine its appropriateness for the journal. MS In Review... the manuscript has been assigned to an editor and may be awaiting reviewer selections, or the awaiting reviews. Decision Pending... the manuscript has been reviewed and the editor is in the process of making a decision. MS in Revision (Optional)... a decision to accept the paper with optional revisions (as suggested in the reviewer or editor comments) has been made by the editor, and a letter requesting these revisions has been sent to the author. Resubmission is anticipated. MS in Revision (Minor)... a decision to accept the paper with minor revisions (as suggested in the reviewer or editor comments) has been made by the editor, and a letter requesting these revisions has been sent to the author. Resubmission is anticipated. MS in Revision (Major)... a decision to reconsider the paper after major revisions (as suggested in the reviewer or editor comments) has been made by the editor, and a letter requesting these revisions has been sent to the author. Resubmission is permitted. MS Rejected... a decision to decline publication has been made by the editor, and a rejection letter has been sent to the author. MS Accepted... a decision to accept the paper has been made by the editor, and an acceptance letter has been sent to the author. MS Withdrawn... the manuscript has been withdrawn at the author's request. No resubmission is permitted. Any further version must be considered as a brand new submission. MS Deactivated... the manuscript has been deactivated due to the author's non-response in resubmitting a revised version or, in some instances, to the editor's invitation to submit a solicited paper. MS Published... the review process is complete and the manuscript is awaiting publication or it has already been published. Invitation/Submit Invited Paper... the editor has extended to you an invitation to submit a paper on a proposed topic. You are asked to reply by using the "Reply to Invitation" button. If you and the editor are in agreement, you can submit the invited paper by using the "Submit Invited MS" button.
2008 年创刊的Brain Stimulation《脑刺激》,ISSN: 1935-861X,季刊,美国(ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710 )出版,2009年入选 Web of Science的Science Citation Index Expanded,目前在SCI数据库可以检索到该期刊2008年的第1卷第1期到2009年的第2卷第3期共67篇论文。 67 篇文章包括学术论文36篇、社论11篇、评论11篇、通讯7篇、更正2篇。 67 篇文章的主要国家分布:美国43篇、德国19篇、英国10篇、意大利10篇、澳大利亚7篇、法国7篇、巴西6篇、加拿大5篇、新西兰5篇、比利时2篇、以色列2篇、日本2篇、中国2篇(其中台湾地区1篇)等。 《脑刺激》旨在成为神经调节原始研究领域中的一流杂志,刊载原始论文、简报、评论、技术与方法展望、读者来信等。 Brain Stimulation《脑刺激》网址: http://www.sciencedirect.com/science/journal/1935861X 作者指南: http://www.elsevier.com/wps/find/journaldescription.cws_home/712317/authorinstructions 在线投稿: http://ees.elsevier.com/brs/ Editorial Board Editor-in-Chief: Mark S. George MD Medical University of South Carolina, Charleston, SC Founding Editor: Harold A. Sackeim PhD Columbia University, New York, NY Deputy Editors: Clinical Neurophysiology John Rothwell PhD University College, Queen Square, London, UK Cognitive Neuroscience Vincent Walsh PhD University College London, London, UK Neurology Mark Hallett MD National Institutes of Health (NIH), Bethesda, MD Pharmacology Ulf Ziemann MD Johann Wolfgang Goethe-University, Frankfurt, Germany Theory and Modelling Cameron C. McIntyre PhD Cleveland Clinic Foundation, Cleveland, OH Neurosurgery Andres Lozano MD, PhD Toronto Western Hospital, Toronto, Canada Basic Science Randolph J. Nudo PhD University of Kansas, Kansas City, KS Medical Center Editorial Board: Robert E. Adamec, PhD Department of Psychology, Memorial University, Newfoundland, Canada Chittaranjan Andrade MD Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India Gary Aston-Jones PhD MUSC Dept of Neurosciences, Charleston, SC, USA Richard J. Bandler PhD Department of Anatomy and Histology, University of Sydney, Sydney, Australia Robert Belmaker MD Ben Gurion University, Department of Psychiatry, Beersheva, Israel Alim Louis Benabid MD Department of Preclinical Neurobiology, Joseph Fourier University, Grenoble, France Jeong-Ho Chae MD, PhD Department of Psychiatry, St. Mary's Hospital, The Catholic University of Korea A.D. (Bud) Craig PhD Atkinson Research Laboratory, Barrow Neurological Institute, Phoenix, AZ, USA Vicenzo Di Lazzaro PhD Institute of Neurology, Universita Cattolica, Rome, Italy Dominique M. Durand PhD Department of Biomedical Engineering, Neural Engineering Center, Case Western Reserve University, Cleveland, OH, USA Jerome Engel MD, PhD UCLA Seizure Disorder Center, David Geffen School of Medicine, Los Angeles, CA, USA Charles M. Epstein MD Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA Paul B. Fitzgerald MBBS, PhD Alfred Psychiatry Research Centre, The Alfred and Monash University, Department of Psychological Medicine, Melbourne, Victoria, Australia Izhak Fried MD, PhD Division of Neurosurgery, Semel Institute of Neuroscience and Human Behavior University of California, Los Angeles, CA, USA Benjamin D. Greenberg MD, PhD Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI, USA Warren M. Grill PhD Department of Biomedical Engineering, Duke University, Durham NC, USA Scott E. Krahl PhD Division of Neurosurgery, University of California, Los Angeles, CA, USA Michal Lavidor PhD Cognitive Neuroscience Laboratory, The Gonda Multidisciplinary Brain Research Center, Bar Ilan University, Ramat Gan, Israel Yongjie Li MD Department of Neurology, Beijing Kuangwuju Hospital, Beijing, China Olle Lindval PhD Laboratory of Neurogenesis and Cell Therapy, Section of Restorative Neurology, Wallenberg Neuroscience Center, Lund, Sweden Helen S. Mayberg MD Emory University School of Medicine, Department of Psychiatry, Atlanta, GA, USA Douglas B. McCreery PhD Neural Engineering Program, Huntington Medical Research Institutes, Pasadena, CA, USA Martha J. Morrell MD Department of Neurology, Stanford University Medical Center, Stanford, CA, USA Ziad H. Nahas MD Department of Psychiatry, Medical University of South Carolina, Charleston, SC, USA Walter Paulus MD Department of Clinical Neurophysiology, Gottingen, Germany Tomas Paus MD, PhD Brain and Body Centre, University of Nottingham, University Park, Nottingham, UK Robert M. Post MD Bethesda, MD, USA Ali R. Rezai MD Center for Neurological Restoration, Cleveland Clinic Foundation, Cleveland, OH, USA Simone Rossi MD, PhD Department of Neuroscience, Section of Neurology, University of Siena, Siena, Italy Thomas E. Schlaepfer MD Department of Psychiatry and Psychotherapy, University Hospital Bonn, Germany Hartwig Siebner MD, PhD Danish Research Centre for Magnetic Resonance, Department of MR, Copenhagen University Hospital Hvidovre, Copenhagen, Denmark A.P. Strafella, MD, PhD Toronto Western Hospital, Research Institute, University of Toronto, Toronto, Ontario, Canada Peter Tass MD, PhD Institute of Neuroscience and Biophysics Medicine Research Center Julich, Julich, Germany Michael R. Trimble MD Raymond Way Unit, Institute of Neurology, University College London, London, UK Yoshikazu Ugawa MD, PhD Fukushima Medical University, Fukushima, Japan Abraham Zangen PhD Weizmann Institute of Science, Department of Neurobiology, Rehovot, Israel